Home > Strategies


Home > Overview


Our Strategy

Diversify Investments in Canada and other countries

Building international footprint with established national leaders

Funding new drug delivery systems and helping nutraceuticals become mainstream drugs

Introducing companies to Canada as a viable option for public listings for companies

Becoming a premier go-to lender for established companies

Our Revenue

Interest bearing debt instruments with asset backed collateral to securitize loans

Equity kicker of warrants coverage on original loan

Conversion ability of loan in its entirety

Advisory fees from contracts for consulting on growth strategies

Right of first refusal on future financing in each company funded